Key result
Average preferences in the target population remain the best metric to evaluate procedures like percutaneous coronary intervention, despite individual variations in quality of life impact.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“FFR-guided percutaneous coronary intervention has a higher initial cost than medical therapy. However, the cost gap narrows more than 50 percent by one year. Since angina and quality of life are significantly improved by PCI, results of this study indicate that FFR-guided PCI appears to be economically attractive in an analysis of cost-effectiveness.”
“We have robust data from COURAGE, FAME 2, and ISCHEMIA clearly showing better angina relief and improved quality of life with revascularization and in particular PCI compared with medical therapy, and at no increased cost in cardiac events. In fact, in FAME 2 at 5 years there was a significant reduction in all MI, and in ISCHEMIA there was a significant reduction in spontaneous MI. At 3 years, the costs between PCI and medical therapy in FAME 2 were no different and the PCI group still had significant angina relief despite a crossover rate of about 50% in the medical therapy arm.”
“This analysis showed that FFR-guided PCI in combination with medical therapy worked better than medical therapy alone after three years and saved money.”
The authors argue that average population preferences remain the best metric for evaluating procedures despite variations in individual preferences for angina relief.
We thank Drs Fan and He for their interest in our article. They raise a number of issues that have both philosophical and technical dimensions. We agree that patients may vary in the degree to which their symptoms reduce quality of life, and that an individual may be more (or less) willing to have a procedure to relieve angina. Although individuals do vary in their preferences, the average in preferences in the target population is still the best metric to evaluate procedures that apply to populations.
No takes yet. Share an insight, caveat, or question.
Fearon et al. (2014) conducted a letter in Stable Coronary Artery Disease and Abnormal Fractional Flow Reserve. Percutaneous Coronary Intervention was evaluated. Average preferences in the target population remain the best metric to evaluate procedures like percutaneous coronary intervention, despite individual variations in quality of life impact.
Synapse has enriched 10 related papers. Consider them for comparative context: